Comparison of Constitutive Gene Expression Levels of Hepatic Cholesterol Biosynthetic Enzymes between Wistar-Kyoto and Stroke-Prone Spontaneously Hypertensive Rats

DOI Web Site Web Site PubMed 参考文献9件
  • Nemoto Kiyomitsu
    Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
  • Ikeda Ayaka
    Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
  • Ito Sei
    Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
  • Miyata Misaki
    Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
  • Yoshida Chiaki
    Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
  • Degawa Masakuni
    Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka

この論文をさがす

抄録

Serum total cholesterol amounts in the stroke-prone hypertensive rat (SHRSP) strain are lower than in the normotensive control strain, Wistar-Kyoto (WKY) rat. To understand the strain difference, constitutive gene expression levels of hepatic cholesterol biosynthetic enzymes in male 8-week-old SHRSP and WKY rats were comparatively examined by DNA microarray and real-time reverse transcription-polymerase chain reaction (RT-PCR) analyses. Of 22 cholesterol biosynthetic enzyme genes, expression levels of 8 genes, Pmvk, Idi1, Fdps, Fdft1, Sqle, Lss, Sc4mol, and Hsd17b7, in SHRSP were less than 50% those of the WKY rats; especially, the expression level of Sqle gene, encoding squalene epoxidase, a rate-limiting enzyme in cholesterol biosynthesis pathway, was about 20%. The gene expression level of sterol regulatory element-binding protein-2 (SREBP-2), which functions as a transcription factor upregulating gene expression of cholesterol biosynthetic enzymes, in SHRSP was about 70% of that in WKY rats. These results demonstrate the possibility that the lower serum total cholesterol level in SHRSP is defined by lower gene expression of most hepatic cholesterol biosynthetic enzymes. In particular, decreased gene expression level of Sqle gene might be the most essential factor. Moreover, the broad range of lowered rates of these genes in SHRSP suggests that the abnormal function and/or expression not only of SREBP-2 but also of one or more other transcription factors for those gene expressions exist in SHRSP.

収録刊行物

参考文献 (9)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ